Skip to Main Content
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Category: Project Optimus
Executive Summary How Project Optimus Is Reshaping Oncology Development A panel of experts at BIO 2025 explored the transformative impact of Project Optimus, a Read Now Blog Highlights from Clinical Trials in Oncology West Coast 2025 Exploring innovation, patient-centricity, and operational excellence in trials I was thrilled to attend the annual Read Now Webinar Best Practices for Operationalizing Global, Early-Phase Oncology Trials The early-phase oncology clinical trial landscape is constantly evolving, influenced by shifts in regulatory guidance Read Now Blog The Growing Complexity of Conducting Oncology Trials Changing regulations, challenging study designs, and globalization Early-phase trial designs are becoming more complex following Read Now Patient meeting with doctor who is taking notes with sunshine coming in from the background. Blog Highlights from HubXchange Immunotherapies Maryland 2024 Optimizing dose and leveraging biomarkers for enhanced patient safety in immunotherapy trials HubXchange Immunotherapies brought Read Now Child on man's shoulders who is holding a kite with lots of sunshine Webinar The New Era of Project Optimus Implications for Oncology Development Strategy Initially drafted in January 2023 and finalized in August 2024, Read Now White Paper Navigating Project Optimus and the Rapidly Changing Oncology Development Landscape Imagine a world where cancer treatments are more effective while also being safer for patients. Read Now Multicolored pills on white background. Blog FDA Finalizes Project Optimus Guidance for Dosing and Expectations for First-in-Human Oncology Trials The past 18 months have been Read Now A smiling Keya Watkins gesturing at a podium at Clinical Trials in Oncology. Blog Navigating the Changing Landscape of Clinical Trials Takeaways from the Clinical Trials in Oncology East Coast I was thrilled to recently chair Read Now Graphic of Benefits of Working with Catalyst Oncology versus a large generalist CRO with an image of two people bathed in sunshine. Article Benefits of Working with Catalyst Oncology versus a Large Generalist CRO Oncology drug development continues to increase in its complexity. Large contract research organizations (CROs) are Read Now
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.